PROVIDER PROFILE · NPI 1356634612

Mahshid MohseniMD

EndocrinologySaint Louis, MOI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

3,190

Unique beneficiaries

—

Total services

62,946

Distinct HCPCS

Medicare payment

$1.0M

Peer benchmark

Total Medicare services vs. 144 Endocrinology providers in MO — top quintile (cohort median 929).

PRESCRIBING · PART D · 2024

Total Rx claims

760

Beneficiaries

—

Total drug cost

$655K

Distinct drugs

Brand share

31.8%

Top prescribed drugs

Alendronate Sodium390 claims

Teriparatide79 claims

Abaloparatide64 claims

Ergocalciferol (Vitamin D2)54 claims

Levothyroxine Sodium50 claims

QUALITY · MIPS · 2024

Final MIPS score

84.2

Quality

71.6

Cost

75.7

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.39%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$94

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$94

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history